AIFM2,ÏßÁ£ÌåµòÍöÓÕµ¼Òò×Ó2¿¹Ìå
²úÆ·±àºÅHZ-7655R
Ó¢ÎÄÃû³ÆAIFM2
ÖÐÎÄÃû³ÆÏßÁ£ÌåµòÍöÓÕµ¼Òò×Ó2¿¹Ìå
±ð Ãûaifm2; AIFM2_HUMAN; AMID; Apoptosis inducing factor (AIF) homologous mitochondrion associated inducer of death; Apoptosis inducing factor (AIF) like mitochondrion associated inducer of death; Apoptosis inducing factor mitochondrion associated 2; Apoptosis-inducing factor 2; Apoptosis-inducing factor homologous mitochondrion-associated inducer of death; Apoptosis-inducing factor-like mitochondrion-associated inducer of death; Cys51Stop; p53 responsive gene 3 p53 tumor suppressor p53-responsive gene 3 protein PRG3 TRP53 Tumor protein p53.
¹æ¸ñ¼Û¸ñ0.1ml 0.2ml
˵ Ã÷ Êé0.1ml 0.2ml
AIFM2,ÏßÁ£ÌåµòÍöÓÕµ¼Òò×Ó2¿¹ÌåÑо¿ÁìÓòϸ°ûÉúÎï ϸ°ûµòÍö
¿¹ÌåÀ´Ô´Rabbit
¿Ë¡ÀàÐÍPolyclonal
½»²æ·´Ó¦Human, Mouse, Rat, Pig, Cow, Sheep,
²úÆ·Ó¦ÓÃWB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 £¨Ê¯À¯ÇÐÆ¬Ðè×ö¿¹ÔÐÞ¸´£©
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
·Ö ×Ó Á¿41kDa
ϸ°û¶¨Î»Ï¸°û½¬ ϸ°ûĤ
ÐÔ ×´Lyophilized or Liquid
Ũ ¶È1mg/1ml
Ãâ Òß ÔKLH conjugated synthetic peptide derived from human AMID/AIFM2
ÑÇ ÐÍIgG
´¿»¯·½·¨affinity purified by Protein A
´¢ ´æ Òº0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
±£´æÌõ¼þStore at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
AIFM2,ÏßÁ£ÌåµòÍöÓÕµ¼Òò×Ó2¿¹ÌåPubMedPubMed
²úÆ·½éÉÜbackground:
Oxidoreductase, which may play a role in mediating a p53/TP53-dependent apoptosis response. Probable oxidoreductase that acts as a caspase-independent mitochondrial effector of apoptotic cell death. Binds to DNA in a sequence-independent manner. May contribute to genotoxin-induced growth arrest. Tissue specificity: Detected in most normal tissues as two transcripts of 1.8 and 4.0 kb in length, respectively. Highly expressed in heart, moderately in liver and skeletal muscles, and expressed at low levels in placenta, lung, kidney, and pancreas. Both transcripts expressed following p53/TP53 induction. The shorter 1.8 kb transcript seems to be the major transcript in EB1 colon cancer cells.
Subcellular Location:
Cytoplasm. Mitochondrion outer membrane.
Tissue Specificity:
Detected in most normal tissues as two transcripts of 1.8 and 4.0 kb in length, respectively. Highly expressed in heart, moderately in liver and skeletal muscles, and expressed at low levels in placenta, lung, kidney, and pancreas. Both transcripts expressed following p53/TP53 induction. The shorter 1.8 kb transcript seems to be the major transcript in EB1 colon cancer cells.
DISEASE:
Similarity:
Belongs to the FAD-dependent oxidoreductase family.
Gene ID:
84883
AIFM2,ÏßÁ£ÌåµòÍöÓÕµ¼Òò×Ó2¿¹ÌåDatabase links:
Entrez Gene: 84883 Human
Entrez Gene: 71361 Mouse
Omim: 605159 Human
SwissProt: Q9BRQ8 Human
SwissProt: Q8BUE4 Mouse
Unigene: 655377 Human
Unigene: 286309 Mouse
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.